Quantity of eligible individuals: CDEC talked about the uncertainty in the amount of sufferers with moderately extreme to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some patients who are categorised as owning delicate or reasonable condition might have a serious ble… Read More